References N Mohammadi E, Louwies T, Pietra C, Northrup SR, Greenwood-Van Meerveld B
"Orforglipron has now demonstrated superiority over two active comparators in clinical trials for type 2 diabetes," said Jeff Emmick, senior vice president of product development, Lilly Cardiometabolic Health
Clinical evaluation should include comprehensive metabolic assessment with fasting glucose, hemoglobin A1C, lipid panel, and thyroid function tests
00:03:09 Vickie Danaher Both are oral once daily GLP-1 agonists that work to slow gastric emptying
Transforming growth factor-3 regulates adipocyte number in subcutaneous white adipose tissue